Focus Lighting H1 FY23 EBITDA up by 638%

Revenue for H1 FY23 at 67.55 Crore, 50% YoY growth

EBITDA for H1 FY23 at 11.59 Crore, 638% YoY growth

Net Profit for H1 FY23 at 6.83 Crore, 16,975% YoY growth

Mumbai (Maharashtra) [India]: Focus Lighting & Fixtures Limited. (NSE – FOCUS), engaged in manufacturing & innovative lighting solutions of LED lights and fixtures, announced its unaudited Financial Results for the Quarter and Half Year ended September 30, 2022.

Key Financials at a Glance (Q2 FY23):

– Total Income for Q2 FY23 at ₹ 40.61 Crore against ₹ 23.15 Crore in Q2 FY22, 75% YoY growth EBITDA for Q2 FY23 at ₹ 8.30 Crore against ₹ 1.86 Crore in Q2 FY22, 346% YoY growth EBITDA Margin for Q2 FY23 at 20.44% against 8.03% in Q2 FY22, 1,240 bps YoY growth

– Net Profit for Q2 FY23 at ₹ 4.59 Crore against ₹ 1.58 Crore in Q2 FY22, 191% YoY growth

– Net Profit Margin for Q2 FY23 at 11.30% against 6.83% in Q2 FY22, 448 bps YoY growth

– EPS for Q2 FY23 at ₹ 4.53 against ₹ 1.56 in Q2 FY22, 190% YoY growth H1 FY23

– Total Income for H1 FY23 at ₹ 67.55 Crore against ₹ 45.18 Crore in H1 FY22, 50% YoY growth EBITDA for H1 FY23 at ₹ 11.59 Crore against ₹ 1.57 Crore in H1 FY22, 638% YoY growth EBITDA Margin for H1 FY23 at 17.16% against 3.47% in H1 FY22, 1,368 bps YoY growth

– Net Profit for H1 FY23 at ₹ 6.83 Crore against ₹ 0.04 Crore in H1 FY22, 16,975% YoY growth Net Profit Margin for H1 FY23 at 10.11% against 0.09% in H1 FY22, 1,002 bps YoY growth EPS for H1 FY23 at ₹ 6.74 against ₹ 0.04 in H1 FY22, 16,750% YoY growth.

Key Financial Highlights:

– For H1 FY23, Cash Flow from Operation stood at ₹ 5.02 Crore against ₹ 0.61 Crore in H1 FY22

– For H1 FY23, Revenue from Manufacturing activities contributed ₹ 49.54 Crore against ₹ 19.65 Crore in H1 FY22

– For H1 FY23, Revenue from Trading activities contributed ₹ 17.32 Crore against ₹ 25.12 Crore in H1 FY22

– For H1 FY23, Manufacturing activities contributed ₹ 8.67 Crore in PBT against a loss of ₹ 0.73 Crore in H1 FY22.

– For H1 FY23, Trading activities contributed ₹ 0.98 Crore in PBT against ₹ 1.24 Crore in H1 FY22.

Commenting on the performance, Mr. Amit Sheth, Managing Director of Focus Lighting And Fixtures, said, “For the H1 FY22, we have seen demand coming back to the pre-pandemic levels, and our margins have improved significantly on the back of diversifying into new business verticals like Projects and Railways which will also provide good margin business because of the government’s push towards increasing make in India contribution.

Also, our thrust on increasing manufacturing contribution has helped us achieve higher operating margins.

Further, our innovative lighting solutions are one of the preferred brands among leading retail giants, which has helped us increase our turnover and margins over the previous year.”

About Focus Lighting & Fixtures Limited:

Focus Lighting & Fixtures Limited (NSE – FOCUS) The company was established in 2005. The company currently provides a wide range of products which includes recessed adjustable spotlights, recessed downlights, surface-mounted spotlights, surface-mounted / suspended downlights, system-based spotlights/wall washers, track-mounted spotlights, etc., each with different working capabilities. Its comprehension of lighting technology, the influence it can have on the viewer, and the techno-aesthetic requirement of the market have enticed it to develop lighting solutions where the criteria are efficiency, color rendition and trouble-free service life to achieve optimum lighting parameters such as luminous intensity, maintenance-friendliness and freedom from glare. The new range of luminaires has been designed and developed by the finest product designers from Germany, proficient in the field of lighting design, supported by a proficient team of Indian Professionals. The company has its manufacturing unit in Sanand, Gujarat.

Post-pandemic, the Company has emerged strongly by doubling its revenues to ₹ 106.6 Crore in FY22 compared with ₹ 60.84 Crore in FY21, while the bottom line is back in the black at ₹ 4.10 Crore as against a loss of ₹ 2.28 Crore in the same period.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

104 thoughts on “Focus Lighting H1 FY23 EBITDA up by 638%

  1. п»їMedicament prescribing information. drug information and news for professionals and consumers.
    ivermectin
    Prescription Drug Information, Interactions & Side. Read now.

  2. Actual trends of drug. Some are medicines that help people when doctors prescribe.
    [url=https://stromectolst.com/#]ivermectin 500ml[/url]
    Commonly Used Drugs Charts. Get information now.

  3. earch our drug database. All trends of medicament.
    order stromectol
    What side effects can this medication cause? Learn about the side effects, dosages, and interactions.

  4. Everything about medicine. Comprehensive side effect and adverse reaction information.
    https://edonlinefast.com best ed medications
    Prescription Drug Information, Interactions & Side. safe and effective drugs are available.

  5. drug information and news for professionals and consumers. drug information and news for professionals and consumers.
    https://canadianfast.online/# legal to buy prescription drugs without prescription
    Medscape Drugs & Diseases. Get information now.

  6. Get here. Drugs information sheet.
    [url=https://canadianfast.com/#]buy prescription drugs[/url]
    Get information now. Everything about medicine.

  7. Comprehensive side effect and adverse reaction information. Comprehensive side effect and adverse reaction information.
    sildenafil tablets online
    Prescription Drug Information, Interactions & Side. Best and news about drug.

  8. drug information and news for professionals and consumers. Drugs information sheet.
    discount cialis
    Everything what you want to know about pills. Some are medicines that help people when doctors prescribe.

  9. Best and news about drug. п»їMedicament prescribing information.
    https://tadalafil1st.com/# cialis mit dapoxetine
    Learn about the side effects, dosages, and interactions. What side effects can this medication cause?

  10. Commonly Used Drugs Charts. Get warning information here.

    https://prednisoned.top/ online prednisone

    [url=https://propeciaf.store/]where to buy cheap propecia pills[/url]
    Drugs information sheet. Medicament prescribing information.

  11. Definitive journal of drugs and therapeutics. Drug information.

    https://clomidc.fun/ can i order clomid for sale
    Some are medicines that help people when doctors prescribe. Read now.

  12. Incredible post. Articles that have significant and savvy remarks are more agreeable, at any rate to me.
    It’s fascinating to peruse what other individuals thought무료스포츠중계I really enjoyed your post.

Leave a Reply

Your email address will not be published.

Releated

Offering ultimate summer chill to consumers, Havmor Ice Cream becomes official ice cream partner for Gujarat Titans Team and ropes in Hardik Pandya as the brand ambassador  

L-R: Mr. Youngdong Jin – COO-HavmorIce Cream, Wrridhiman Saha, Rahul Tewatia , Shivam Mavi, Mr. Komal Anand, Managing Director,HavmorIce Cream, KS Bharat, Pradeep Sangwan, and Mr. Arvinder Singh, Chief Operating Officer, Gujarat Titans  To mark the association, Havmor ice cream unveiled a campaign with brand ambassador Hardik Pandya Launches limited edition ice cream range with […]

Ravi Kumar SAGAR, founder and CEO of RK’s Inno Group, receives Raj Bhavan Yuva Ugadi Puraskar 2023 from Telangana Governor

Hyderabad (Telangana) [India], March 24: Ravi Kumar SAGAR, founder and CEO of RK’s Inno Group, was honoured with the Young Entrepreneur Award 2023, Raj Bhavan Yuva Ugadi Purasakar 2023 from Her Excellency Governor Dr. Tamilisai Soundararajan in Telangana. This prestigious award is a testament to Ravi’s commitment to excellence in business and his positive impact […]